Filtros de búsqueda

Lista de obras de Shai Mulinari

A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding

artículo científico publicado en 2021

An intersectional approach to multilevel analysis of individual heterogeneity (MAIH) and discriminatory accuracy.

artículo científico publicado en 2017

Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: multilevel analysis of discriminatory accuracy.

artículo científico publicado en 2016

Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation

artículo científico publicado en 2015

DRhoGEF2 and diaphanous regulate contractile force during segmental groove morphogenesis in the Drosophila embryo

artículo científico publicado en 2008

Divergence and convergence of commercial and scientific priorities in drug development: The case of Zelmid, the first SSRI antidepressant

artículo científico publicado en 2015

Does Maternal Country of Birth Matter for Understanding Offspring's Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden

artículo científico publicado en 2015

Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

scientific article published on 19 August 2019

Expression and regulation of Spätzle-processing enzyme in Drosophila.

artículo científico publicado en 2006

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs

artículo científico publicado en 2020

Genetics and democracy-what is the issue?

artículo científico publicado en 2012

Hedgehog, but not Odd skipped, induces segmental grooves in the Drosophila epidermis.

artículo científico publicado en 2009

Indolent handling of the pharmaceutical industry harms the The Medical Products Agency's credibility

artículo científico publicado el 14 de noviembre de 2012

Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches

artículo científico publicado en 2017

Measures of discriminatory accuracy and categorizations in public health: a response to Allan Krasnik's editorial

artículo científico publicado en 2015

Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation

artículo científico publicado en 2013

Monoamine theories of depression: historical impact on biomedical research.

artículo científico

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012

artículo científico publicado en 2016

Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.

artículo científico publicado en 2017

Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden

artículo científico publicado en 2015

Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics? ⬇️

artículo científico publicado el 24 de octubre de 2012

Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny

article

Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power

artículo científico publicado en 2019

Rho-guanine nucleotide exchange factors during development: Force is nothing without control

artículo científico publicado en 2010

Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden.

artículo científico publicado en 2017

Testosterone prescribing in the population-a short social epidemiological analysis in Sweden

artículo científico publicado en 2015

The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning.

artículo científico publicado en 2014

The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza

scientific article published on 19 November 2019

Two-Thirds of Survey Respondents in Southern Sweden Used Complementary or Alternative Medicine in 2015

artículo científico publicado en 2017

Unhealthy marketing of pharmaceutical products: An international public health concern

artículo científico publicado en 2016

Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews

artículo científico publicado en 2017

[Not too late for reform]

[Why lie about the causes of depression?]

scientific article published on 01 September 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda